<DOC>
	<DOCNO>NCT00816764</DOCNO>
	<brief_summary>This first human study AGS-8M4 give every 2 week subject advanced ovarian cancer . AGS-8M4 administer IV infusion disease worsens .</brief_summary>
	<brief_title>A Phase 1 Study Safety Pharmacokinetics AGS-8M4 Subjects With Advanced Ovarian Cancer</brief_title>
	<detailed_description>All Subjects receive AGS-8M4 treatment . Subjects enrol sequentially 1 4 plan dose cohort accord standard dose escalation study design . A disease assessment perform study week 9 ( +/- 3 day ) . The assessment base clinical sign symptom , change radiographic image , change CA-125 level . Subjects without evidence disease progression may continue receive AGS-8M4 extended treatment period dose schedule assign cohort disease progression intolerability AGS-8M4 consent withdrawal . For subject continue dose , disease assessment perform every 8 week extend treatment period . A safety follow-up visit occur 4 week last infusion AGS-8M4 .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Ovarian Diseases</mesh_term>
	<criteria>Subjects recurrent disease histologically cytologically confirm Stage III/IV diagnosis epithelial ovarian cancer , fallopian tube cancer , primary peritoneal carcinoma Subjects must receive least one prior platinum contain regimen one following : persistent disease ( either stable disease , partial response nonmeasureable disease first line therapy ) progressive disease anytime No epithelial ovarian tumor low malignant potential Active infection require treatment systemic antiinfectives within 72 hour screen Use investigational drug within 30 day prior screen 5 halflives prior investigational drug ( whichever longer ) Prior monoclonal antibody therapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>clinical trial , phase 1</keyword>
	<keyword>carcinoma</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>ovarian</keyword>
</DOC>